Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of ABC008 in the Treatment of Subjects With Inclusion Body Myositis

NCT05721573 is registered in ClinicalTrials.gov with Abcuro, Inc. as lead sponsor.

NCT NCT05721573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05721573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of ABC008 in the Treatment of Subjects With Inclusion Body Myositis
Lead sponsor
Abcuro, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
February 28, 2023
Completion date
November 27, 2025
Enrollment
272 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

inclusion body myositis